Home

Quick Product Lists

  View Cart

In Business 34 Years - Since 1980

 

 

View this page in English

 

Diese Seite ansehen in Deutsch

 

A-C Alphabetical List of Products

 


D-F

G-K

L-O

P-R

S-Z


Product #

Name

A-1803

A-769662, >99%

A-6880

17-AAG, >99%

 

AB-1010 — see Masitinib, Free Base, Cat. No. M-7007.

 

ABT-578 — see Zotarolimus, Free Base, Cat. No. Z-9040.

 

AC010220 — see Quizartinib, Free Base, Cat. No. Q-4747.

 

AC220 — see Quizartinib, Free Base, Cat. No. Q-4747.

 

Acadesine — see AICAR, Free Base, Cat. No. A-1098.

A-6900

6"-O-Acetyldaidzin, >98%

A-3000

6"-O-Acetylgenistin, >98%

A-7860

6"-O-Acetylglycitin, >98%

 

Adeo — see (R,S)-Rolipram, Cat. No. R-2020.

 

Adriacin — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

 

Adriamycin — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

 

Adriblastin — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

 

Adriblastina — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

A-8644

Afatinib, Free Base,>99%

 

Afinitor — see its active ingredient, namely Everolimus, Cat. No. E-4040.

 

AG 490 — see Tyrphostin AG 490, Cat. No. T-9142.

 

AG 1478 — see Tyrphostin AG 1478, Cat. No. T-7310.

 

AG-013736 — see Axitinib, Free Base, Cat. No. A-1107.

 

AGL-1872 — see PP1, Free Base, Cat. No. P-6420.

 

AIC-riboside — see AICAR, Free Base, Cat. No. A-1098.

 

AICA-riboside — see AICAR, Free Base, Cat. No. A-1098.

A-1098

AICAR, Free Base, >99%

 

Alimta — see its active ingredient, namely Pemetrexed, Disodium Salt, Heptahydrate, Cat. No. P-7177.

 

Alkaban-AQ — see its active ingredient, namely Vinblastine, Sulfate Salt, Cat. No. V-7300.

 

17-(Allylamino)-17-Demethoxygeldanamycin — see 17-AAG, Cat. No. A-6880.

 

17-(Allylamino)geldanamycin — see 17-AAG, Cat. No. A-6880.

 

Alvespimycin — see 17-DMAG, Cat. No. D-3440.

A-3465

Alvocidib, Free Base, >98%

 

AMG-706 — see Motesanib, Diphosphate Salt, Cat. No. M-2999 and Motesanib, Free Base, Cat. No. M-2900.

 

2'-Amino-3'-methoxyflavone — see PD 98059, Cat. No. P-4313.

 

5-Aminoimidazole-4-carboxamide riboside — see AICAR, Free Base, Cat. No. A-1098.

 

AMN-107 — see Nilotinib, Cat. No. N-8207.

 

AMPK Inhibitor I — see Dorsomorphin, Dihydrochloride Salt, Cat. No. D-3456 and Dorsomorphin, Free Base, Cat. No. D-3197.

 

3-Angeloyl Ingenol — see Ingenol 3-Angelate, Cat. No. I-5900.

 

3-Angelyl Ingenol — see Ingenol 3-Angelate, Cat. No. I-5900.

 

Anthra(1,9-cd)pyrazol-6(2H)-one — see SP600125, Cat. No. S-7979.

 

Anthrapyrazolone — see SP600125, Cat. No. S-7979.

 

Antibiotic AM-2282 — see Staurosporine, Cat. No. S-9300.

 

Antibioitic S 7481F1 — see Cyclosporin A, Cat. No. C-6000.

 

AP 23573 — see Ridaforolimus, Cat. No. R-7040.

 

AP 24534 — see Ponatinib, Free Base, Cat. No. P-7022.

 

Arasine — see its active ingredient, namely AICAR, Free Base, Cat. No. A-1098.

 

Armala — see Pazopanib, Free Base, Cat. No. P-6706.

 

ARRY-142886 — see Selumetinib, Free Base, Cat. No. S-4490.

 

ARRY-886 — see Selumetinib, Free Base, Cat. No. S-4490.

 

Ascotoxin — see Brefeldin A, Cat. No. B-8500.

 

AT-877 — see Fasudil, Monohydrochloride Salt, Cat. No. F-4660.

 

ATM Kinase Inhibitor — see KU-55933, Cat. No. K-5050.

 

ATS 1287B — see Leptomycin B, Free Acid, Cat. No. L-6100.

 

AUY922 — see NVP-AUY922, Free Base, Cat. No. N-5300.

 

AV-951 — see Tivozanib, Free Base, Cat. No. T-6466.

A-1107

Axitinib, Free Base, >99%

 

AY-22989 — see Rapamycin, Cat. No. R-5000.

 

5-Aza-CdR — see Decitabine, Free Base, Cat. No. D-3899.

 

5-Aza-dC — see Decitabine, Free Base, Cat. No. D-3899.

 

AzadC — see Decitabine, Free Base, Cat. No. D-3899.

 

5-Aza-2'-deoxycytidine — see Decitabine, Free Base, Cat. No. D-3899.

 

5-Azadeoxycytidine — see Decitabine, Free Base, Cat. No. D-3899.

 

Azaepothilone B — see Ixabepilone, Free Base, Cat. No. I-5022.

 

AZD-0530 — see S-8906 Saracatinib, Free Base, Cat. No. D-0530.

 

AZD2171 — see Cediranib, Free Base, Cat. No. C-4300.

 

AZD-2281 — see Olaparib, Cat. No. O-9201.

A-1088

AZD4547, Free Base, >99%

 

AZD6244 — see Selumetinib, Free Base, Cat. No. S-4490.

A-2345

AZD8055, Free Base, >99%

 

B705008K112 — see Bryostatin 1, Cat. No. B-6697.

 

Baccatin III N-benzyl-β-phenylisoserine ester — see Paclitaxel, Cat. No. P-9600.

B-1080

Bafilomycin A1, >98%

 

Bay 43-9006 — see Sorafenib, p-Toluenesulfonate Salt, Cat. No. S-8502 and Sorafenib, Free Base, Cat. No. S-8599.

 

4'-N-Benzoyl Staurosporine — see PKC412, Cat. No. P-7600.

 

Benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone — see Z-VAD-FMK, Methyl Ester, Cat. No. Z-9900.

 

Benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone — see Z-VAD-FMK, Free Acid, Cat. No. Z-9999.

B-2422

Bexarotene, Free Acid, >99%

 

BEZ235 — see NVP-BEZ235, Free Base, Cat. No. N-4288.

 

BFA — see Brefeldin A, Cat. No. B-8500.

 

BIBF1120 — see Nintedanib, Free Base, Cat. No. N-9077.

 

BIBF1120 Esylate — see Nintedanib, Ethanesulfonate Salt, Cat. No. N-9055.

 

BIBW-2992 — see Afatinib, Free Base, Cat. No. A-8644.

B-7100

BIIB021, Free Base, >99%

 

BIRB 796 — see Doramapimod, Free Base, Cat. No. D-2744.

 

BML-275 — see Dorsomorphin, Dihydrochloride Salt, Cat. No. D-3456 and Dorsomorphin, Free Base, Cat. No. D-3197.

 

BMP Inhibitor I — see Dorsomorphin, Dihydrochloride Salt, Cat. No. D-3456 and Dorsomorphin, Free Base, Cat. No. D-3197.

 

BMS-247550 — see Ixabepilone, Free Base, Cat. No. I-5022.

 

BMS-247550-1 — see Ixabepilone, Free Base, Cat. No. I-5022.

 

BMS-354825 — see Dasatinib, Free Base, Cat. No. D-3307.

 

BMY-40481 — see Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444.

B-1408

Bortezomib, Free Base, >99%

B-1788

Bosutinib, Free Base, >99%

B-1722

Bosutinib Isomer 1, Free Base, >99%

B-1709

Explanation of the Bosutinib Problem and Bosutinib Isomer 1

B-8500

Brefeldin A, >99%

B-6697

Bryostatin 1, >99%

B-3517

Bryostatin 2, >99%

C-2581

Cabazitaxel, >99%

 

Caelyx — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

C-3987

Calyculin A, >98%

 

Campto — see its active ingredient, namely Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122.

 

Camptosar — see its active ingredient, namely Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122.

 

Camptothecin 11 — see Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122.

C-1201

Canertinib, Dihydrochloride Salt, >99%

 

Capecitabin — see Capecitabine, Cat. No. C-2799.

C-2799

Capecitabine, >99%

 

Capecitibine — see Capecitabine, Cat. No. C-2799.

 

Capecytabine — see Capecitabine, Cat. No. C-2799.

 

Capiibine — see Capecitabine, Cat. No. C-2799.

 

Caprelsa — see Vandetanib, Cat. No. V-9402.

 

Captabin — see Capecitabine, Cat. No. C-2799.

C-3022

Carfilzomib, Free Base, >99%

C-2662

Carnosic Acid, Free Acid, >99%

 

Caspase Inhibitor VI — see Z-VAD-FMK, Free Acid, Cat. No. Z-9999.

 

Caxeta — see Capecitabine, Cat. No. C-2799.

 

CCG-168 — see AZD8055, Free Base, Cat. No. A-2345.

 

CCI-779 — see Temsirolimus, Cat. No. T-8040.

C-4300

Cediranib, Free Base, >99%

 

Celebra — see its active ingredient, namely Celecoxib, Cat. No. C-1502.

 

Celebrex — see its active ingredient, namely Celecoxib, Cat. No. C-1502.

 

Celecox — see Celecoxib, Cat. No. C-1502.

C-1502

Celecoxib, >99%

 

CEP-701 — see Lestaurtinib, Cat. No. L-6307.

 

CEP-18770 — see Delanzomib, Free Base, Cat. No. D-4011.

 

Certican — see its active ingredient, namely Everolimus, Cat. No. E-4040.

 

cFMS Receptor Tyrosine Kinase Inhibitor — see GW2580, Free Base, Cat. No. G-5903.

 

CGP41251 — see PKC412, Cat. No. P-7600.

 

CGP-57148B — see Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508.

 

CGP-79787 — see Vatalanib, Dihydrochloride Salt, Cat. No. V-8303.

 

CHIR-258 — see Dovitinib, Free Base, Cat. No. D-3608 and Dovitinib, Lactate Salt, Kat.-Nr. D-3699.

 

CHIR 911 — see CHIR99021, Free Base, Cat. No. C-6556.

C-6556

CHIR99021, Free Base, >99%

 

CI-940 — see Leptomycin B, Free Acid, Cat. No. L-6100.

 

CI-1033 — see Canertinib, Dihydrochloride Salt, Cat. No. C-1201.

 

CI-1040 — see PD 184352, Free Base, Cat. No. P-8499.

 

Ciclosporin A — see Cyclosporin A, Cat. No. C-6000.

 

CIP 18770 — see Delanzomib, Free Base, Cat. No. D-4011.

 

CL-1957A — see Leptomycin B, Free Acid, Cat. No. L-6100.

 

CNF-101 — see 17-AAG, Cat. No. A-6880.

 

CNF2024 — see BIIB021, Free Base, Cat. No. B-7100.

 

Cocarcinogen A1 — see Phorbol 12-Myristate 13-Acetate, Cat. No. P-1680.

 

Colforsin — see Forskolin, Cat. No. F-9929.

 

Compound C — see Dorsomorphin, Dihydrochloride Salt, Cat. No. D-3456 and Dorsomorphin, Free Base, Cat. No. D-3197.

 

CP 127374 — see 17-AAG, Cat. No. A-6880.

 

CP-358774 — see Erlotinib, Free Base, Cat. No. E-4997 and Erlotinib, Hydrochloride Salt, Cat. No. E-4007.

 

CP-690550 — see Tofacitinib, Free Base, Cat. No. T-1377.

 

CP-690550-10 — see Tofacitinib, Citrate Salt, Cat. No. T-1399.

 

CP-690550 Citrate — see Tofacitinib, Citrate Salt, Cat. No. T-1399.

 

CPB — see Alvocidib, Free Base, Cat. No. A-3465.

 

CPT-11 — see Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122.

C-7900

Crizotinib, Free Base, >99%

 

CsA — see Cyclosporin A, Cat. No. C-6000.

 

CSF-1 Receptor Inhibitor — see GW2580, Free Base, Cat. No. G-5903.

 

CT53518 — see Tandutinib, Free Base, Cat. No. T-7802.

 

CT-47098 — see Delanzomib, Free Base, Cat. No. D-4011.

 

CT99021 — see CHIR99021, Free Base, Cat. No. C-6556.

 

Cyanein — see Brefeldin A, Cat. No. B-8500.

 

CYC202 — see Roscovitine, Cat. No. R-1234.

C-8700

Cyclopamine, Free Base, 99%

C-6000

Cyclosporin A, >99%

 

Cyclosporine — see Cyclosporin A, Cat. No. C-6000.


Back to top

Home

Quick Product Lists

View Cart

Our products are for laboratory research only and are sold only to qualified research institutions, not to individuals or patients nor for veterinary use.